Malvern, Australia

Neeranat Theinthong

This inventor holds 1 USPTO granted patent. Top assignee: Avexa Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neeranat Theinthong. Retrieved from https://idiyas.com/inventor/neeranat-theinthong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neeranat Theinthong: Innovator in Antiviral Compounds

Introduction

Neeranat Theinthong is a notable inventor based in Malvern, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with antiviral properties. His work is essential in the ongoing fight against viral infections.

Latest Patents

Neeranat holds 1 patent for his invention titled "Compounds having antiviral properties." This patent provides a compound of formula (I) or a pharmaceutically acceptable derivative, salt, or prodrug thereof. The invention also outlines a method for treating or preventing viral infections in subjects by administering an effective amount of the compound. Additionally, pharmaceutical compositions that include this compound are also described in the patent.

Career Highlights

Neeranat Theinthong is associated with Avexa Limited, a company focused on developing innovative treatments for viral infections. His work at Avexa Limited has positioned him as a key player in the pharmaceutical industry, contributing to advancements in antiviral therapies.

Collaborations

Neeranat has collaborated with notable colleagues, including John Joseph Deadman and Eric Dale Jones. These partnerships have fostered a collaborative environment that enhances the development of effective antiviral solutions.

Conclusion

Neeranat Theinthong's contributions to antiviral compounds highlight his innovative spirit and dedication to improving public health. His work continues to pave the way for new treatments in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…